Page 36 - Anjali Singh

Biocon Biologics completes integration of Viatris' biosimilars business

Biocon Biologics bought Viatris' global biosimilars business last year to become one of the top five global players in the space

Indian companies likely to garner up to 50% USFDA nod share in 2023

Companies may get up to 375 ANDA approvals in 2023, more than last year's 355

Cipla invests Rs 42 crore in GoApptiv to enhance healthcare access

Cipla's move aligns with its vision to strengthen investments in channels and technologies

Kinetic's high-speed e-scooter Zulu comes with battery subscription plan

The battery subscription model is claimed to have reduced the acquisition cost by over 35 per cent and offers significant savings on running costs

FAME subsidy needed for 3-5 years: Kinetic Green founder and CEO

Motwani spoke about the need to have subsidies under Faster Adoption and Manufacturing of (Hybrid &) Electric Vehicles (FAME) for three-five year

Hospital industry set to grow at 12% CAGR driven by post-pandemic recovery

This surge in growth has led to an increase in capital expenditure within the hospital industry

Full charge ahead: E2W sales likely to breach 1 million mark in 2024

Likely to be driven by increasing penetration in rural areas

Max Healthcare Institute acquires Starlit Medical Centre for Rs 940 crore

Within its current network, it has 3,533 beds, and following this acquisition, the total bed count would approximately touch around 4,083 beds

GlaxoSmithKline completes VRS scheme as part of its business review

GlaxoSmithKline Pharmaceuticals has also established an Omnichannel Team, leveraging technology to enhance its reach and coverage across target segments

Luxury carmaker Lamborghini's Revuelto sold out in India, globally for 2026

Lamborghini is confident that its strong sales and investment in electrification will continue to drive its success in India and around the world

Lord's Mark Industries set to go public in 2024, aims to raise Rs 500 cr

IDBI Capital and Mirae Asset have been appointed as the merchant bankers for the listing

National TB elimination programme includes Mylab's advanced diagnostic kit

India carries a significant burden of TB cases, with the annual TB cases rising by 19 per cent in 2021

Bharat Biotech, University of Sydney ink MoU for vaccine research

The international agreement aims to foster strong collaborations between sectors and organisations to develop innovative methods for tackling future epidemics and infectious diseases

Musashi targets 25% market share in EV transmission components by 2028

This investment will be used to establish new assembly lines for EV transmission components and to upgrade existing facilities

Rusan Pharma Invests 300 Crores in New API Facility in MP's Pithampur

New plant to produce 400 MT of APIs, creating more than 300 jobs and enhancing global supply

BMC allocates Rs 1,500 crore for the upcoming healthcare schemes

BMC has also revealed that they are allocating Rs 3,500 crore for capital expenditure in the next couple of months and are planning to recruit 3,000 healthcare professionals

Ryzneuta for chemotherapy-induced neutropenia receives USFDA approval

Acrotech Biopharma is preparing to commercialise Ryzneuta in the United States in the near future

Pharma company Laurus Labs acquires 87.59% stake in Laurus Bio Private

The acquisition was made through a secondary purchase from the promoter group shareholders of Laurus Bio on November 20, 2023

India's workforce faces rising medical inflation, reveals report

The report also revealed nearly 59 per cent skip their annual health checkups, while 90 per cent neglect regular doctor consultations to monitor their health

Cipla's Pithampur unit gets USFDA warning; analysts remain bullish

The letter, dated November 17, 2023, highlights contraventions regarding methods or controls at the facility that do not conform to prescribed GMP regulations